1. Home
  2. CCLD vs IPSC Comparison

CCLD vs IPSC Comparison

Compare CCLD & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCLD
  • IPSC
  • Stock Information
  • Founded
  • CCLD 1999
  • IPSC 2019
  • Country
  • CCLD United States
  • IPSC United States
  • Employees
  • CCLD N/A
  • IPSC N/A
  • Industry
  • CCLD Computer Software: Prepackaged Software
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • CCLD Technology
  • IPSC Health Care
  • Exchange
  • CCLD Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • CCLD 52.5M
  • IPSC 58.1M
  • IPO Year
  • CCLD 2014
  • IPSC 2021
  • Fundamental
  • Price
  • CCLD $1.91
  • IPSC $0.54
  • Analyst Decision
  • CCLD Buy
  • IPSC Strong Buy
  • Analyst Count
  • CCLD 2
  • IPSC 5
  • Target Price
  • CCLD $3.00
  • IPSC $3.67
  • AVG Volume (30 Days)
  • CCLD 689.0K
  • IPSC 719.6K
  • Earning Date
  • CCLD 05-06-2025
  • IPSC 05-20-2025
  • Dividend Yield
  • CCLD N/A
  • IPSC N/A
  • EPS Growth
  • CCLD N/A
  • IPSC N/A
  • EPS
  • CCLD N/A
  • IPSC N/A
  • Revenue
  • CCLD $112,507,000.00
  • IPSC $6,589,000.00
  • Revenue This Year
  • CCLD $3.18
  • IPSC $833.10
  • Revenue Next Year
  • CCLD $5.81
  • IPSC N/A
  • P/E Ratio
  • CCLD N/A
  • IPSC N/A
  • Revenue Growth
  • CCLD N/A
  • IPSC 194.81
  • 52 Week Low
  • CCLD $1.04
  • IPSC $0.34
  • 52 Week High
  • CCLD $4.84
  • IPSC $3.47
  • Technical
  • Relative Strength Index (RSI)
  • CCLD 56.01
  • IPSC 51.91
  • Support Level
  • CCLD $1.73
  • IPSC $0.52
  • Resistance Level
  • CCLD $2.44
  • IPSC $0.57
  • Average True Range (ATR)
  • CCLD 0.18
  • IPSC 0.03
  • MACD
  • CCLD 0.05
  • IPSC 0.00
  • Stochastic Oscillator
  • CCLD 50.00
  • IPSC 58.75

About CCLD CareCloud Inc.

CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Share on Social Networks: